Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03584282 · ClinicalTrials.gov registry record · NA

Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users

A NA study of HIV/AIDS and Drug Use, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
21
Enrollment target
2
Study locations

NCT03584282 is a NA study of HIV/AIDS and Drug Use that has completed, run by University of Washington. The registered enrollment target is 21 participants, below the 33,180-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03584282, a NA study of HIV/AIDS and Drug Use, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
2
Study locations

Study Summary

Despite increasing knowledge about and use of PrEP nationally, HIV continues to have disproportionate impact among cisgender men and transgender persons who have sex with men and transgender persons (MSM/TG), with methamphetamine (meth)-users being at particularly high risk. Building on their preliminary work, the investigators will pilot text messaging and peer navigation interventions to support PrEP use among meth-using MSM/TG with potential to be cost-effective, scalable, and easily adaptable.

Conditions Studied

HIV/AIDS Drug Use Adherence, Medication

Interventions

  • BEHAVIORAL Text Messaging
  • BEHAVIORAL Peer Navigation

Study Locations (2)

Washington

  • Kelley-Ross One-Step PrEP - Seattle
  • Gay City - Seattle

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2018-07-11
Est. Completion 2022-06-30
Phase NA

Sponsor

University of Washington

1,048 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03584282

The ClinicalTrials.gov registry entry for NCT03584282 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 33,180-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV/AIDS appearing as the primary indexed condition, and to 2 interventions - of which Text Messaging is the first listed.

NCT03584282 reports 2 study locations spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT03584282 about?

NCT03584282 is a clinical study titled "Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users". Despite increasing knowledge about and use of PrEP nationally, HIV continues to have disproportionate impact among cisgender men and transgender persons who have sex with men and transgender persons (MSM/TG), with methamphetamine (meth)-users being at particularly high risk. Building on their prelim...

What is the current status of trial NCT03584282?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2018-07-11. Estimated completion is 2022-06-30.

What conditions does trial NCT03584282 study?

This clinical trial studies the following conditions: HIV/AIDS, Drug Use, Adherence, Medication.

What interventions are being tested in trial NCT03584282?

The interventions under investigation include: Text Messaging (BEHAVIORAL), Peer Navigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03584282?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03584282 being conducted?

This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV/AIDS

All registered trials for this condition

Drug Use

All registered trials for this condition

Washington

All trials with a study site in Washington

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.